139 related articles for article (PubMed ID: 22457123)
1. Genetic suppression of Gαs protein provides rate control in atrial fibrillation.
Lugenbiel P; Thomas D; Kelemen K; Trappe K; Bikou O; Schweizer PA; Voss F; Becker R; Katus HA; Bauer A
Basic Res Cardiol; 2012 May; 107(3):265. PubMed ID: 22457123
[TBL] [Abstract][Full Text] [Related]
2. Suppression of persistent atrial fibrillation by genetic knockdown of caspase 3: a pre-clinical pilot study.
Trappe K; Thomas D; Bikou O; Kelemen K; Lugenbiel P; Voss F; Becker R; Katus HA; Bauer A
Eur Heart J; 2013 Jan; 34(2):147-57. PubMed ID: 21785105
[TBL] [Abstract][Full Text] [Related]
3. If inhibition in the atrioventricular node by ivabradine causes rate-dependent slowing of conduction and reduces ventricular rate during atrial fibrillation.
Verrier RL; Bonatti R; Silva AF; Batatinha JA; Nearing BD; Liu G; Rajamani S; Zeng D; Belardinelli L
Heart Rhythm; 2014 Dec; 11(12):2288-96. PubMed ID: 25111327
[TBL] [Abstract][Full Text] [Related]
4. Connexin 43 gene therapy prevents persistent atrial fibrillation in a porcine model.
Bikou O; Thomas D; Trappe K; Lugenbiel P; Kelemen K; Koch M; Soucek R; Voss F; Becker R; Katus HA; Bauer A
Cardiovasc Res; 2011 Nov; 92(2):218-25. PubMed ID: 21799069
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory G protein overexpression provides physiologically relevant heart rate control in persistent atrial fibrillation.
Bauer A; McDonald AD; Nasir K; Peller L; Rade JJ; Miller JM; Heldman AW; Donahue JK
Circulation; 2004 Nov; 110(19):3115-20. PubMed ID: 15505099
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of I(f) in the atrioventricular node as a mechanism for dronedarone's reduction in ventricular rate during atrial fibrillation.
Verrier RL; Sobrado MF; Pagotto VP; Kanas AF; Machado AD; Varone BB; Sobrado LF; Nearing BD; Zeng D; Belardinelli L
Heart Rhythm; 2013 Nov; 10(11):1692-7. PubMed ID: 23933296
[TBL] [Abstract][Full Text] [Related]
7. Genetic suppression of atrial fibrillation using a dominant-negative ether-a-go-go-related gene mutant.
Soucek R; Thomas D; Kelemen K; Bikou O; Seyler C; Voss F; Becker R; Koenen M; Katus HA; Bauer A
Heart Rhythm; 2012 Feb; 9(2):265-72. PubMed ID: 21907172
[TBL] [Abstract][Full Text] [Related]
8. Coupled pacing improves left ventricular function during simulated atrial fibrillation without mechanical dyssynchrony.
Lim P; Yanulis GE; Verhaert D; Greenberg NL; Grimm RA; Tchou PJ; Lellouche N; Wallick DW
Europace; 2010 Mar; 12(3):430-6. PubMed ID: 20118112
[TBL] [Abstract][Full Text] [Related]
9. Distinct contractile and molecular differences between two goat models of atrial dysfunction: AV block-induced atrial dilatation and atrial fibrillation.
Greiser M; Neuberger HR; Harks E; El-Armouche A; Boknik P; de Haan S; Verheyen F; Verheule S; Schmitz W; Ravens U; Nattel S; Allessie MA; Dobrev D; Schotten U
J Mol Cell Cardiol; 2009 Mar; 46(3):385-94. PubMed ID: 19100271
[TBL] [Abstract][Full Text] [Related]
10. Dynamic ventricular overdrive stimulation in atrial fibrillation: effects on ventricular rate irregularity, ventricular pacing, and fusion beats.
Nölker G; Gutleben KJ; Asbach S; Ritscher G; Marschang H; Sinha AM; Boileau P; Benser ME; Hallier B; Hümmer A; Brachmann J
Europace; 2011 Dec; 13(12):1688-94. PubMed ID: 21784744
[TBL] [Abstract][Full Text] [Related]
11. Heart rate variability in patients suffering from structural heart disease and decreased AV-nodal conduction capacity. Insights into the formation of heart rate variability.
Schwab JO; Eichner G; Schmitt H; Schrickel J; Yang A; Balta O; Lüderitz B; Lewalter T
Z Kardiol; 2004 Mar; 93(3):229-33. PubMed ID: 15024591
[TBL] [Abstract][Full Text] [Related]
12. Focal pharmacological modulation of atrioventricular nodal conduction via implantable catheter: a novel therapy for atrial fibrillation?
Sigg DC; Hiniduma-Lokuge P; Coles JA; Falkner P; Rose R; Urban JF; Ujhelyi MR
Circulation; 2006 May; 113(20):2383-90. PubMed ID: 16702470
[TBL] [Abstract][Full Text] [Related]
13. Impact of atrioventricular node ablation and pacing therapy on clinical course in patients with permanent atrial fibrillation and unstable ventricular tachycardia induced by rapid ventricular response: follow-up study.
Petrac D; Radićc B; Radeljić V; Hamel D; Filipović J
Croat Med J; 2005 Dec; 46(6):929-35. PubMed ID: 16342346
[TBL] [Abstract][Full Text] [Related]
14. Xanthine oxidase inhibition prevents atrial fibrillation in a canine model of atrial pacing-induced left ventricular dysfunction.
Sakabe M; Fujiki A; Sakamoto T; Nakatani Y; Mizumaki K; Inoue H
J Cardiovasc Electrophysiol; 2012 Oct; 23(10):1130-5. PubMed ID: 22587612
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic effects of selective atrioventricular node vagal stimulation in atrial fibrillation and heart failure.
Zhang Y; Popović ZB; Kusunose K; Mazgalev TN
J Cardiovasc Electrophysiol; 2013 Jan; 24(1):86-91. PubMed ID: 22913453
[TBL] [Abstract][Full Text] [Related]
16. Autologous dermal fibroblast injections slow atrioventricular conduction and ventricular rate in atrial fibrillation in swine.
Tondato F; Zeng H; Goodchild T; Ng FS; Chronos N; Peters NS
Circ Arrhythm Electrophysiol; 2015 Apr; 8(2):439-46. PubMed ID: 25638212
[TBL] [Abstract][Full Text] [Related]
17. Biological Heart Rate Reduction Through Genetic Suppression of Gα(s) Protein in the Sinoatrial Node.
Lugenbiel P; Bauer A; Kelemen K; Schweizer PA; Becker R; Katus HA; Thomas D
J Am Heart Assoc; 2012 Apr; 1(2):. PubMed ID: 23130123
[TBL] [Abstract][Full Text] [Related]
18. Biventricular pacing improves cardiac function and prevents further left atrial remodeling in patients with symptomatic atrial fibrillation after atrioventricular node ablation.
Orlov MV; Gardin JM; Slawsky M; Bess RL; Cohen G; Bailey W; Plumb V; Flathmann H; de Metz K
Am Heart J; 2010 Feb; 159(2):264-70. PubMed ID: 20152225
[TBL] [Abstract][Full Text] [Related]
19. [Modulation of atrioventricular conduction in patients with atrial fibrillation or flutter. Immediate and long-term results].
Carbucicchio C; Lavarra F; Riva S; Fassini G; Della Bella P
Cardiologia; 1995 Dec; 40(12):927-40. PubMed ID: 8901043
[TBL] [Abstract][Full Text] [Related]
20. Heart rate regularisation in patients with permanent atrial fibrillation implanted with a VVI(R) pacemaker.
Mazzocca G; Giovannini T; Frascarelli F; Fabiani A; Burali A; Giappichini G; Bidi G; Bernabò D; Manfredini E; Corbucci G
Europace; 2004 May; 6(3):236-42. PubMed ID: 15121077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
